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Abstract
Background:
Patients with Pulmonary Tuberculosis (PTB) often develop impairment in pulmonary function due to anatomical changes 
secondary to the illness. Physiotherapy in the form of  pulmonary rehabilitation has been advocated.
Objective:The aim of  the study was to determine whether adherence to a six-week home-based pulmonary rehabilitation 
programme (PRP) improved the baseline measurements of  lung function, exercise tolerance and health-related quality of  
life (HRQoL) in patients receiving out-patient treatment for PTB.
Method: A single blinded randomized control study design was used to assess the effects of  a six-week home- based PRP 
in patients receiving treatment for PTB at a local clinic in Khayelitsha, Western Cape. We evaluated lung function by spirom-
etry (MINATO AUTOSPIRO-model no. AZ-505), exercise tolerance using the 6-min-walk test (6MWT), the Borg exercise 
exertion scale and HRQoL using the EQ-5 D questionnaire in an intervention group (n=34) and a control group (n=33). 
The trend of  the effects of  the PRP on lung function was towards increases, but there was no statistical difference between 
the intervention and control groups at the end of  the sixth week in the values of  FVC (p=0.2; 95% CI -0.9 to 0.51) as well 
as FEV1 (p=0.1; 95% CI -0.07 to 0.51). Similar trend was observed for exercise tolerance, and there was no significant dif-
ference in HRQoL (p=0.789).
Conclusion: The outcome of  the study provides motivation for further consideration and implementation of  a pulmonary 
rehabilitation programme for patients with PTB. 
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Introduction:
Despite the advances in care of  patients with Pulmo-
nary Tuberculosis (PTB) in the acute phase1, these 
advances have yet to encompass their long term man-
agement. Recent literature in the field has shown that 
pulmonary impairment after PTB is still present after 
cure,1,2 and patients often complained of  inability to 
cope with physical activities that they previously per-
formed on daily basis3.  Internationally  pulmonary 
rehabilitation  guidelines  have  been  developed  for 
patients suffering from Chronic Obstructive Airway 
Disease (COAD)2. Research in this area has shown that 
pulmonary   programmes   can   improve   not   only 
the   pulmonary   function   and cardiovascular fitness 
of  patients but also impact positively on their Health-
Related Quality of  Life (HRQoL)4,5,. Although PTB 
has not traditionally been classified into the category 
of  COAD6, recent studies show that chronic obstruc-
tive airway disease is present even after six months of  
microbiological cure7. Thus, it is hypothesised that due 
to the sequelae patients suffer, they would benefit from 
pulmonary rehabilitation7.
However, the health seeking behaviour of  PTB pa-
tients, including those with the comorbidity of  HIV, 
are negatively affected by the current poor health care 
infrastructure in South Africa3. In addition, there has 
been little focus on physiotherapy related interven-
tions for patients with PTB, which could address the 
impairment after PTB cure. The National Tuberculosis 
Strategic Plan for South Africa (2007-2011)8  encour-
ages community and patient empowerment in order to 
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improve the capacity of  patients to better control their 
own health and assist other patients in improving their 
own lives. Therefore, the intention of  this study was to 
determine whether a six week home-based Pulmonary 
Rehabilitation Programme5  (PRP) would assist in the 
improvement of   pulmonary  function,  exercise  toler-
ance  and  HRQoL  for  patients  with  PTB  before  the 




Routinely, PTB patients require hospitalisation until 
they are well enough to be treated at a clinic or in the 
community. The study was conducted between June-
September 2009 at the Ubuntu TB and HIV Clinic situ-
ated at Khayelitsha Site B Community Health Centre 
in Cape Town, South Africa.  Khayelitsha suburb, an 
under resourced community, had an incidence rate of  
1122/100 000 in 20039. In the same year, the health-
care complex in the community serviced a total of  4566 
TB cases, most of  whom were also HIV positive10. The 
community has one of  the highest prevalence of  PTB 
and HIV infection on a national as well as on interna-
tional scale10. It must be acknowledged however that 
South Africa is still dealing with issues of  equity in ac-
cess to healthcare in the post-apartheid era11,12.
Study subjects and design:
For inclusion into this study, all adult PTB participants 
between the ages of  18 and 65 years needed to be am-
bulant as the home based pulmonary rehabilitation 
programme includes lower limb exercises. The partici-
pants were also required to be contactable by telephone 
for follow-up appointments, pass the Physical Activ-
ity Readiness Questionnaire (Par-Q) assessment, and 
attend the clinic for four consecutive months to meet 
eligibility into the study. The sample size was calculat-
ed using Statistica Version 8. It was estimated that the 
treatment group would be able to walk about 340m dur-
ing the 6 minute walk test and the control group would 
be able to walk 50m less, with a standard deviation of  
77m. A sample size of  31 was therefore required in each 
group to establish a significant difference at a p level of  
0.05 and a power of  80%13. 
Ethical approval to conduct the study was obtained 
from both the University of  Cape Town
(HREC 251/2009) as well as the City of  Cape Town. 
One hundred and thirty patients who agreed to take part 
in the study were assessed by the principal researcher 
(first author) using the Par-Q questionnaire which is 
often used to determine the safety or possible risk of  
exercising for an individual based upon their answers 
to specific health history questions. One hundred and 
two patients were selected to participate in the study 
(Figure 1). 
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The principal researcher then administered a question-
naire specifically designed to obtain demographic infor-
mation about the patients, the HRQoL questionnaire, 
and tested lung function and exercise tolerance, to pro-
vide base line data for the participants.
Using a single blinded randomized control study de-
sign14, the selected participants were then randomly al-
located by an independent research assistant into either 
the intervention group (IG) or the control group (CG). 
The independent research assistant carried out the
intervention  programs  for  the  two  groups  over 
the  period of  6 weeks5,6.  The  principal researcher, 
who was blinded to the group allocation, repeated the 
administration of  the HRQoL questionnaire, the lung 
function test, and the exercise tolerance test at 3 and 6
weeks after the baseline assessment, during follow up 
visits.
Instrumentation:
A detailed explanation of  the study and procedure 
was provided by the principal researcher before the in-
formed consent document was signed and any testing 
performed. To assess the lung function, an automotive 
desktop spirometer (MINATO AUTOSPIRO-model 
no. AZ-505) was used to measure the Forced Expira-
tory Volume in one second (FEV1) and Forced Vital 
capacity (FVC) of  all participants15,16. Exercise toler-
ance testing was performed using the six-minute- walk 
test15,16, during which the distance covered by each par-
ticipant within the allocated time was  recorded.  The 
15-Grade  Modified  Borg  Scale  (MBS)4,16 was  used  to 
assess  rate  of  perceived exertion (RPE) after the six-
minute walk test. The participants were asked to choose 
a number between 6 (no exertion) and 20 (maximal ex-
ertion) which best described their perceived exertion. 
Data pertaining to HRQoL was collected using the EQ-
5D Questionnaire, which is based on the five domains 
of  HRQoL17.
Intervention Programme:
Based on the clinical competency guidelines for Pulmo-
nary Rehabilitation Programme (PRP)14, a home  based 
PRP  was  designed  for  the  participants  in  the  inter-
vention  group  (IG)  and implemented by the research 
assistant. The duration of  the rehabilitation programme 
as used  in an earlier  assessment  of   HRQoL and ex-
ercise tolerance in COAD  participants was utilized  for 
cost  effectiveness  and  time  management  in  a  clinic 
setting6.  
The program included cardiovascular, low-impact exer-
cises such as upper and lower limb range of  movement 
activities, wall push-ups, repeated sit to stand move-
ments, calf  raises, and walking. Participants were ad-
vised to “walk faster” every day when doing the walking 
component of  the program. The pulmonary compo-
nents consisted of  pursed-lipped breathing, diaphrag-
matic breathing, postural correction and the facilitation 
of  coughing. The PRP was thoroughly explained and 
demonstrated to participants in the IG, each receiving 
printed illustrated diagrams of  the exercises as well as 
instructions on repetitions, sets, and durations in Afri-
kaans, English, and Isi Xhosa. Participants in the CG 
were provided with a health education material, also in 
Afrikaans, English, and Isi Xhosa, which included in-
formation on the symptoms, diagnostic tools, treatment 
and prevention of  PTB. This is one of   the  practical 
guidelines  of   the  South African National TB Control 
program. 
 
Summary of  Analysis: 
IBM SPSS version 21 was used for data analysis.  The 
data was approximately normally distributed.  A p value 
<0.05 was considered as statistically significant. Inter-
group changes were tested using a repeated measure 
ANOVA. Changes over time were tested using a time
multiplied  by  treatment   interaction  which  signified 
the  comparative   effect  of   the intervention versus 
control, and a p value <0.05 for the interaction indi-
cated statistical significance. Baseline imbalances were 
accounted for in the analysis.   Profile plots were used 
to  establish  the  direction  and  trend  of   the  effects. 
Responses  to  the  EQ-5D questionnaire were in form 
of  a likert scale and, being a non-parametric data, the 
Mann-Whitney U test was used to compare outcome 
measures between IG and CG. The Modified Borg Scale 
reading was also assessed using Mann-Whitney U test. 
 
Results:
Only 67 participants completed the six week exercise 
programme, with 35 participants lost to follow  up  as 
shown  in  Figure  1  (14  transferred  to other  hospi-
tals,  8 relocated  outside  the province, 3 had difficulty 
with travelling to the clinic, and 10 were not reachable). 
Table 1 shows the demographic profile of  those partici-
pants who completed the six week programme for both 
the intervention and control group. 
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The hospital notes of  the patients were perused for 
clinical information. Information relating to updated 
laboratory tests and radiological reports were not read-
ily accessible for all the patients. Most of  the partici-
pants (69%) were HIV+ and receiving anti-retroviral 
treatment in addition to TB treatment. Participants with 
PTB only (31%) were first time cases,  and  also  under-
going  treatment.  About  two  thirds  of   the  patients 
were  already experiencing  multidrug  resistance.  No 
differences  were  found  between  the  groups  when
tested   for   covariate   analysis   of    gender   (p=1), 
ARV   treatment   (p=1),   educational qualification 
(p=0.61), or smoking history (p=0.74).
Pulmonary function
The mean differences in the lung function at baseline 
between the control and intervention groups (Table 2) 
were not statistically significant in the values of  FEV1 
(p=0.57; 95% CI: -0.22 to  0.39)  and  FVC  (p=0.6; 
95%  CI:  -0.23  to 0.397).  




Gender Male 33 (49%) 16 (49%) 17 (50%) 
Female 34 (51%) 17 (51%) 17 (50%) 
Occupation Employed 17 (25%) 7 (21%) 10 (29%) 
Unemployed 50 (75%) 26 (79%) 24 (71%) 
Level of Education No formal Education 0 0 0 
Primary School 
(Gr. 1-7) 
16 (24%) 11 (33%) 5 (15%) 
High School 
(Gr. 8-11) 
36 (54%) 17 (52%) 19 (56%) 
Completed Gr. 12 15 (22%) 5 (15%) 10 (29%) 
Marital status Married 22 (33%) 11 (33%) 11 (32%) 
Widowed 2 (3%) 0 (0%) 2 (6%) 
Divorced/single 43 (64%) 22 (67%) 21 (62%) 
Smoking History Current smoker 5 (7%) 4 (12%) 1 (3%) 
Ex-smoker 29 (43%) 15 (46%) 14 (41%) 
Never smoked before 33 (49%) 14 (42%) 19 (56%) 
Diagnosis PTB only* 21 (31%) 10 (30%) 11 (32%) 
PTB + HIV# 46 (69%) 23 (70%) 23 (68%) 
ARV'S§ Yes 45 (67%) 22 (67%) 23 (68%) 
 No 22 (33%) 11 (33%) 11 (32%) 
PTB regimen‡ 1 23 (34%) 14 (42%) 9 (26%) 
 2 44 (66%) 19 (58%) 25 (74%) 
 

































CG – Control Group; IG – Intervention Group; *Pulmonary tuberculosis in the absence of comorbidity; #Human 
Immunodeficiency Virus; §Anti-retroviral treatment; ǂPTB regimen 2 is associated with multiple drug-resistant PTB
 
Pulmonary Function readings at baseline 
 CG (n=33) IG (n=34) 
 Mean Range SD Mean Range SD 
FEV1(L) 1.47 0.50-4.15 0.70 1.60* 0.82-3.11 0.56 
FVC (L) 1.54 0.53-4.19 0.71 1.68* 0.94-3.32 0.57 
FEV1/FVC 0.95 0.72-1.00 0.07 0.96 0.77-1.00 0.06 
Pulmonary Function readings at week six 
FEV1 (L) 1.54 0.45-4.10 0.66 1.77 1.07-2.99 0.54 
FVC (L) 1.64 0.54-4.12 0.68 1.86 1.07-3.30 0.58 
FEV1/FVC 0.94 0.64-1.00 0.07 0.96 0.79-1.00 0.06 
 
 













*Statistically significant value (p>0.0
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Similarly,  there  were  no significant differences be-
tween the two groups in week three in FEV1 (p=0.50; 
95% CI: -0.21 to 0.41) and FVC (p=0.50; 95% CI: -0.20 
to 0.42). Again there was no statistically significant dif-
ferences in week six in FEV1  (p=0.1; 95% CI: -0.07 to 
0.51) and FVC (p=0.2; 95% CI: -0.9 to 0.51). Intragroup 
analysis found that both values for FVC (p=0.004; 95% 
CI: -0.36 to -0.07) and FEV1 (p=0.001; 95% CI: -0.33 
to -0.08) (Table 3) were statistically significant when the 
difference between baseline and week 6 was evaluated 
in the intervention group. 
In the control group, only the FVC was found to be sta-
tistically significant (p=0.037; 95% CI: -0.19 to -0.062). 
Repeated measures of  lung function parameters over 
the six week period, adjusting for PTB regimen (p=0.2) 
and smoking history, was not statistically significant in 
FVC (p=0.47) as well as FEV1 (p=0.36).
Pulmonary Function readings at baseline 
 CG (n=10) IG (n=11) 
 Mean Range SD Mean Range SD 
FEV1(L) 1.49 0.87-2.24 0.50 1.67* 0.87-3.11 0.66 
FVC (L) 1.60 0.89-2.53 0.57 1.71* 0.94-3.32 0.70 
FEV1/FVC 0.94 0.78-1.00 0.75 0.98 0.93-1.00 0.03 
Pulmonary Function readings at week six 
FEV1 (L) 1.28 0.45-2.41 0.62 1.98 1.23-2.95 0.65 
FVC (L) 1.39 0.54-2.42 0.62 2.09 1.25-3.17 0.69 
FEV1/FVC 0.91 0.64-1.00 0.11 0.95 0.79-1.00 0.08 
 














*Statistically significant value (p>0.05) 
Exercise tolerance 
In table 4, the difference in distance covered between 
the participants in the IG and the CG was statistically 
significant (p=0.01; 95% CI: 12.16 to 110.1) at baseline, 
at week 3 (p=0.01; 95% CI:13.66 to 103.6), and week 
six (p=0.007; 95% CI: 15.37 to 92.7). 
Table 4: Distance covered in 6-min walk test and rate perceived exertion for the Intervention and 
Control groups (n=67) 
 
 Control Group (n=33) Intervention Group (n=34) 
 Mean Range SD Mean Range SD 
Distance covered (m) 340.00 160-680 104.67 401.18 200-600 96.13 
Borg Scale reading 11.42 7-15 1.64 10.06 7-15 2.32 
WEEK 6 
Distance covered (m) 356.97 190-520 78.72 411.03 235-580 79.79 
Borg Scale reading 11.24 7-15 1.48 10.35 7-13 1.82 
 
 
Similar significant difference was noted in the evalua-
tion of  the Modified Borg Scale in week six (p=0.03) 
between the intervention   and   control   groups.   How-
ever,   adjusting   for   smoking,   PTB  treatment, 
educational level, and ARV treatment, the differences in 
the exercise tolerance parameters were not statistically 
significant (P>0.05).
Health-related quality of  life
The difference between the IG and CG over the 6 week 
period was not statistically significant
(p=0.789). 
Discussion:
Pulmonary Tuberculosis (PTB) has been described 
as a long term disability which has overall detrimen-
tal effects on the physical and social aspects of  PTB 
diagnosed patients16. While pulmonary rehabilitation 
guidelines  have  been  developed  for  patients  with 
COAD2,  similar guidelines are not yet in place in the 
managing the pulmonary impairment in PTB after cure. 
In line with the national Tuberculosis Strategic Plan for 
South Africa which encourages community and patient 
empowerment8, this study was therefore aimed at deter-
mining if  a six-week home based pulmonary rehabilita-
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tion programme would assist in improving pulmonary 
function, exercise tolerance, and health-related quality 
of  life in patient with PTB who are still undergoing
treatment.
Making inferences from the outcome of  this pilot study 
is limiting due to the small sample size, and  the  limited 
clinical  parameters of   the  participants  (updated  radi-
ological  and laboratory reports) which were not readily 
accessible. The researchers were unable to ascertain the 
extent of  lung destruction with the resultant functional 
impairment, and the specific duration for which each 
participant had been on TB medication prior to inclu-
sion in the study. What was assured was that each par-
ticipant had been receiving treatment at the clinic for 
four consecutive months to qualify for inclusion in the 
study. Other information about the patients that were 
not readily accessible to the researchers pertained to the 
HIV/AIDS status, namely CD4 count and viral load.
The socio-demographic profile of  the participants in 
the study was consistent with the scenario relating to 
the historical past of  South Africa11,12. Most of  the 
participants presented with comorbidity of  HIV+ and 
PTB diagnosis (69%), while about two-thirds of  them 
were receiving treatment for multidrug resistant TB. 
The implementation of  the home-based rehabilitation 
programme is in line with international recommenda-
tion of  increased community involvement in the diag-
nosis and management of  tuberculosis as part of  the 
global plan for TB818.
When covariant analysis is carried out, no statistically 
significant difference is found in the parameters as-
sessed between the two groups. The differences re-
ported between the two groups may be attributed to 
chance alone. While the overall difference in lung func-
tion parameters between the IG and CG was not statis-
tically significant, the change that occurred within the 
intervention group from baseline to the 6th week of  
testing was statistically significant. Similarly, the differ-
ence between the IG and CG in the exercise tolerance 
outcome was statistically at the end of  the 6th week. 
These  differences  provide  some  motivation  for  the 
consideration  and implementation of  a pulmonary re-
habilitation programme5,15,16 during PTB treatment to 
limit the pulmonary impairment  experienced after  mi-
crobiological  cure1,2, and  in  turn  the  long  term dis-
ability that contribute to the overall detrimental effects 
on physical and socialaspects of  PTB patients16 . As no 
adverse effects or complications were noted during the 
intervention period, it is recommended that further re-
search be carried out that involves larger sample size in 
multiple research sites, and test further the hypothesis 
that PTB patients would benefit from
pulmonary rehabilitation.
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